RituximabPneumonia following off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1779卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71471-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：207 / 207

相关论文

共 50 条

[41] PrednisoloneInefficacy following off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 405 - 405
[42] NivolumabPsoriasis following an off-label use: case report
Reactions Weekly, 2018, 1717 (1) : 214 - 214
[43] PembrolizumabOral mucositis following off label use: case report
Reactions Weekly, 2018, 1706 (1) : 407 - 407
[44] BevacizumabMyocardial infarction following off label use: case report
Reactions Weekly, 2018, 1701 (1) : 58 - 58
[45] TocilizumabNeutropenia following off-label use: case report
Reactions Weekly, 2021, 1853 (1) : 446 - 446
[46] RituximabAllergic reaction following off label use: case report
Reactions Weekly, 2019, 1783 (1) : 212 - 212
[47] Lopinavir/ritonavirDiarrhoea following off label use: case report
Reactions Weekly, 2021, 1863 (1) : 212 - 212
[48] DaratumumabHypogammaglobulinemia following off-label use: case report
Reactions Weekly, 2019, 1744 (1) : 111 - 111
[49] GlibenclamideHypoglycaemia following off-label use: case report
Reactions Weekly, 2021, 1857 (1) : 162 - 162
[50] TocilizumabAnastomotic leakage following off label use: case report
Reactions Weekly, 2021, 1879 (1) : 339 - 339

← 1 2 3 4 5 →